欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
CD4细胞含量和治疗效果关系密切,是衡量AIDS病人免疫能力的重要指标。本文以武汉市疾病防御中心提供的患者数据为基础,建立了CD4细胞和随访次数间的线性回归模型。得出一般病人接受治疗时处于疾病晚期,经过3个随访周期后能恢复到疾病中期,免疫能力有所提高。并以初始状态的免疫能力为指标将所选病人分为两类。通过比较CD4细胞均值随随访次数变化情况的不同,分析了治疗措施对不同免疫情况病人效果的差异。得出免疫能力越低的病人治疗效果越明显。大约在16次随访之后,初始免疫能力较低的患者CD4细胞均值反超免疫能力高的患者。通过治疗,患者一般能恢复到疾病中期,但免疫能力较低的患者需要更长的时间。建议综合考虑恢复到疾病中期的时间长短和治疗效果的高低来确定病人接受治疗的初始时期。
同期刊论文项目
同项目期刊论文
Adsorbents with high selectivity for uremic middle molecular peptides containing Asp-Phe-Leu-Ala-Glu
Preparative separation of four individual flavonoids in Scutellaria barbata D. Don based on high sel
Application of surface plasmon resonance in screening adsorbents and explaining adsorption phenomena
Qualitative and quantitative relationships between affinity constants from model study and real adso
Colorimetric detection of bis-phosphorylated peptides using zinc(ii) dipicolylamine-appended gold na
Rapid and efficient screening of adsorbent for oligopeptide using molecular docking and isothermal t
High selective purification of flavonoids from natural plants based on polymeric adsorbent with hydr
Preparation and recognition study on the peptides in aqueous media of poly(pyridine derivative-co-ac
Separation of sanguinarine and chelerythrine in Macleaya cordata (Willd) R. Br based on methyl acryl
期刊信息
位置：